Open (posted) · Grant
DoW Reconstructive Transplant, Investigator-Initiated Research Award
Defense Health Agency Contracting Activity - DHACA, Department of Defense
Key facts
Copied from the official Grants.gov record. Last verified October 29, 2026.
- Program name
- DoW Reconstructive Transplant, Investigator-Initiated Research Award
- Issuing agency
- Defense Health Agency Contracting Activity - DHACA (Department of Defense)
- Opportunity number
- HT942526RTRPIIRA
- Funding type
- Grant
- Funding purpose
- Science and Technology and other Research and Development
- Status
- Open (posted)
- Application deadline
- Closes November 4, 2026(5 days left)
- Published award range
- Not published by the agency
- Estimated total program funding
- $8,000,000
- Expected number of awards
- 8
- Cost sharing or match required
- No
- Eligible applicants (official categories)
- Unrestricted (open to any type of entity, subject to any clarification in Additional Information on Eligibility)
- Relevant to
- Businesses and NonprofitsHow we determined this: Grants.gov lists eligibility as Unrestricted.
- Geographic restrictions
- None stated in structured data (federal opportunities are often nationwide). Check the eligibility details and full announcement for any limits.
- Assistance Listing (CFDA)
- 12.420
- Official source
- View on Grants.gov ↗
- Application URL
- www.grants.gov/search-results-detail/363455 ↗Apply through Grants.gov (Workspace) using the application package on the official listing, unless the full announcement names a different submission system.
- Source identifier
- Grants.gov opportunity ID 363455 · Funding opportunity number HT942526RTRPIIRA
- Posted
- August 26, 2026 · Source last updated August 26, 2026
- Last verified
- October 29, 2026 (against Grants.gov)
- Data completeness
- 83% of key fields published by the sourceNot published: published funding range, eligibility criteria text.
- Record confidence
- highVerified against the official source; key fields present; no open issues.
Description (from the official listing)
Summary: The fiscal year 2026 (FY26) Reconstructive Transplant Research Program (RTRP) Investigator-Initiated Research Award supports studies that have the potential to make an important contribution to reconstructive transplant research, patient care, and/or quality of life. All projects must demonstrate solid scientific rationale with military-relevant utility. The Investigator-Initiated Research Award does not support clinical trials. Distinctive Features: · Scope: Applications may focus on any phase of research from basic through translational, including preclinical studies in animal models, and clinical research in human subjects or human anatomical substances. · Study Design and Feasibility: The study design should be rigorous and support maximal reproducibility and translational feasibility. A strong statistical plan with appropriate power analysis is important. · Impact: Project results should have the potential for long- and short-term impact on the reconstructive transplant research field and/or patient community. Projects should address at least one of the FY26 RTRP Focus Areas. · Preliminary Data: Preliminary and/or published data that are relevant to reconstructive transplantation and support the rationale for the proposed research must be included. · Military Relevance: All projects must be responsive to the health care needs of military Service Members and/or Veterans recovering from traumatic injury, and/or their Family members, caregivers, or clinicians, as well as the general public. Collaboration with military researchers and clinicians is encouraged but…
Read the full description
Summary: The fiscal year 2026 (FY26) Reconstructive Transplant Research Program (RTRP) Investigator-Initiated Research Award supports studies that have the potential to make an important contribution to reconstructive transplant research, patient care, and/or quality of life. All projects must demonstrate solid scientific rationale with military-relevant utility. The Investigator-Initiated Research Award does not support clinical trials. Distinctive Features: · Scope: Applications may focus on any phase of research from basic through translational, including preclinical studies in animal models, and clinical research in human subjects or human anatomical substances. · Study Design and Feasibility: The study design should be rigorous and support maximal reproducibility and translational feasibility. A strong statistical plan with appropriate power analysis is important. · Impact: Project results should have the potential for long- and short-term impact on the reconstructive transplant research field and/or patient community. Projects should address at least one of the FY26 RTRP Focus Areas. · Preliminary Data: Preliminary and/or published data that are relevant to reconstructive transplantation and support the rationale for the proposed research must be included. · Military Relevance: All projects must be responsive to the health care needs of military Service Members and/or Veterans recovering from traumatic injury, and/or their Family members, caregivers, or clinicians, as well as the general public. Collaboration with military researchers and clinicians is encouraged but not required.
Agency contact
eBRAP Help Desk
Phone: 301-682-5507
Email: help@eBRAP.org
help@eBRAP.org